These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


253 related items for PubMed ID: 10565802

  • 1. Inositol augmentation of serotonin reuptake inhibitors in treatment-refractory obsessive-compulsive disorder: an open trial.
    Seedat S, Stein DJ.
    Int Clin Psychopharmacol; 1999 Nov; 14(6):353-6. PubMed ID: 10565802
    [Abstract] [Full Text] [Related]

  • 2. Quetiapine augmentation of serotonin reuptake inhibitors in obsessive-compulsive disorder.
    Mohr N, Vythilingum B, Emsley RA, Stein DJ.
    Int Clin Psychopharmacol; 2002 Jan; 17(1):37-40. PubMed ID: 11800505
    [Abstract] [Full Text] [Related]

  • 3. Olanzapine addition in obsessive-compulsive disorder refractory to selective serotonin reuptake inhibitors: an open-label case series.
    Weiss EL, Potenza MN, McDougle CJ, Epperson CN.
    J Clin Psychiatry; 1999 Aug; 60(8):524-7. PubMed ID: 10485634
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Aripiprazole augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a 10-week open-label study.
    Ak M, Bulut SD, Bozkurt A, Ozsahin A.
    Adv Ther; 2011 Apr; 28(4):341-8. PubMed ID: 21437763
    [Abstract] [Full Text] [Related]

  • 7. A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder.
    Bloch MH, Landeros-Weisenberger A, Kelmendi B, Coric V, Bracken MB, Leckman JF.
    Mol Psychiatry; 2006 Jul; 11(7):622-32. PubMed ID: 16585942
    [Abstract] [Full Text] [Related]

  • 8. Agomelatine augmentation in obsessive compulsive disorder: a preliminary report.
    Tzavellas E, Karaiskos D, Ilias I, Liappas I, Paparrigopoulos T.
    Psychiatriki; 2014 Jul; 25(3):179-84. PubMed ID: 25367661
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Quetiapine augmentation of SRIs in treatment refractory obsessive-compulsive disorder: a double-blind, randomised, placebo-controlled study [ISRCTN83050762].
    Carey PD, Vythilingum B, Seedat S, Muller JE, van Ameringen M, Stein DJ.
    BMC Psychiatry; 2005 Jan 24; 5():5. PubMed ID: 15667657
    [Abstract] [Full Text] [Related]

  • 11. Risperidone and haloperidol augmentation of serotonin reuptake inhibitors in refractory obsessive-compulsive disorder: a crossover study.
    Li X, May RS, Tolbert LC, Jackson WT, Flournoy JM, Baxter LR.
    J Clin Psychiatry; 2005 Jun 24; 66(6):736-43. PubMed ID: 15960567
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Pharmacological augmentation of serotonin reuptake inhibitors in patients with obsessive-compulsive disorder: A network meta-analysis.
    Maiti R, Mishra A, Srinivasan A, Mishra BR.
    Acta Psychiatr Scand; 2023 Jul 24; 148(1):19-31. PubMed ID: 37177823
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Memantine augmentation in treatment-resistant obsessive-compulsive disorder: an open-label trial.
    Aboujaoude E, Barry JJ, Gamel N.
    J Clin Psychopharmacol; 2009 Feb 24; 29(1):51-5. PubMed ID: 19142108
    [Abstract] [Full Text] [Related]

  • 17. Augmentation of serotonin reuptake inhibitors in refractory obsessive-compulsive disorder using adjunctive olanzapine: a placebo-controlled trial.
    Bystritsky A, Ackerman DL, Rosen RM, Vapnik T, Gorbis E, Maidment KM, Saxena S.
    J Clin Psychiatry; 2004 Apr 24; 65(4):565-8. PubMed ID: 15119922
    [Abstract] [Full Text] [Related]

  • 18. Quetiapine addition to serotonin reuptake inhibitors in patients with severe obsessive-compulsive disorder: a double-blind, randomized, placebo-controlled study.
    Kordon A, Wahl K, Koch N, Zurowski B, Anlauf M, Vielhaber K, Kahl KG, Broocks A, Voderholzer U, Hohagen F.
    J Clin Psychopharmacol; 2008 Oct 24; 28(5):550-4. PubMed ID: 18794652
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.